Arcturus Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.908; its P/E ratio is -6.97; Arcturus Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-1.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 30.86M	$ 45.14M	$ 10.52M	$ 80.28M	$ 160.29M
Gross Profit	$ 30.86M	$ 45.14M	$ 10.52M	$ 80.28M	$ 160.29M
EBIT	$ -11.45M	$ -15.33M	$ -51.97M	$ 50.86M	$ 119.14M
EBITDA	$ -10.63M	$ -14.50M	$ -51.24M	$ 51.44M	$ 118.24M
Net Income Common Stockholders	$ -11.71M	$ -16.22M	$ -52.55M	$ 50.75M	$ 117.35M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 292.00M	$ 311.92M	$ 323.47M	$ 327.94M	$ 391.88M
Total Assets	$ 429.40M	$ 457.65M	$ 430.65M	$ 470.86M	$ 450.39M
Total Debt	$ 25.91M	$ 47.02M	$ 28.11M	$ 29.19M	$ 90.87M
Net Debt	$ -266.10M	$ -264.90M	$ -295.36M	$ -298.75M	$ -301.01M
Total Liabilities	$ 150.89M	$ 177.59M	$ 145.47M	$ 141.62M	$ 180.07M
Stockholders Equity	$ 278.51M	$ 280.06M	$ 285.21M	$ 329.25M	$ 270.31M
Cash Flow	-
Free Cash Flow	$ -1.50M	$ -33.39M	$ 50.45M	$ -36.56M	$ 156.45M
Operating Cash Flow	$ -629.00K	$ -32.41M	$ 50.81M	$ -35.87M	$ 160.26M
Investing Cash Flow	$ -875.00K	$ -981.00K	$ -354.00K	$ -691.00K	$ -3.81M
Financing Cash Flow	$ -18.66M	$ 21.84M	$ 94.00K	$ -27.36M	$ -2.23M

Currency in USD

Arcturus Therapeutics Earnings and Revenue History

Income Statement >

Arcturus Therapeutics Debt to Assets

Balance Sheet >

Arcturus Therapeutics Cash Flow

Cash Flow >

Arcturus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing